Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.4M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
+2.91M
-
Total reported value, excl. options
-
$815M
-
Value change
-
+$96.3M
-
Put/Call ratio
-
1.36
-
Number of buys
-
44
-
Number of sells
-
-19
-
Price
-
$33.22
Significant Holders of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) as of Q4 2020
81 filings reported holding PHAT - Phathom Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 71.4M outstanding shares and own 34.38% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (5.83M shares), RA CAPITAL MANAGEMENT, L.P. (3.83M shares), Medicxi Ventures Management (Jersey) Ltd (2.07M shares), Invesco Ltd. (2.05M shares), JANUS HENDERSON GROUP PLC (1.94M shares), VANGUARD GROUP INC (1.44M shares), Ensign Peak Advisors, Inc (1.22M shares), Abingworth LLP (1.2M shares), BlackRock Inc. (791K shares), and EVENTIDE ASSET MANAGEMENT, LLC (600K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.